QS Investors LLC Sells 3,545 Shares of Mylan N.V. (MYL)
QS Investors LLC lessened its holdings in Mylan N.V. (NASDAQ:MYL) by 5.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 67,366 shares of the company’s stock after selling 3,545 shares during the period. QS Investors LLC’s holdings in Mylan N.V. were worth $2,615,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Doliver Capital Advisors LP purchased a new position in shares of Mylan N.V. during the second quarter valued at approximately $201,000. Stifel Financial Corp lifted its stake in shares of Mylan N.V. by 1.2% during the second quarter. Stifel Financial Corp now owns 59,480 shares of the company’s stock valued at $2,310,000 after buying an additional 678 shares during the period. Voya Investment Management LLC lifted its stake in shares of Mylan N.V. by 57.9% during the second quarter. Voya Investment Management LLC now owns 271,506 shares of the company’s stock valued at $10,540,000 after buying an additional 99,584 shares during the period. Veritable L.P. lifted its stake in shares of Mylan N.V. by 34.7% during the second quarter. Veritable L.P. now owns 9,119 shares of the company’s stock valued at $354,000 after buying an additional 2,347 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Mylan N.V. by 20.8% during the second quarter. Dimensional Fund Advisors LP now owns 2,940,967 shares of the company’s stock valued at $114,171,000 after buying an additional 507,098 shares during the period. 71.97% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/qs-investors-llc-sells-3545-shares-of-mylan-n-v-myl/1615210.html.
Shares of Mylan N.V. (MYL) opened at 38.29 on Friday. Mylan N.V. has a 52-week low of $29.39 and a 52-week high of $45.87. The stock has a 50 day moving average of $32.08 and a 200 day moving average of $36.45. The firm has a market cap of $20.53 billion, a price-to-earnings ratio of 30.95 and a beta of 1.30. Mylan N.V. also was the recipient of some unusual options trading activity on Wednesday. Traders purchased 10,562 put options on the company. This represents an increase of 461% compared to the average daily volume of 1,883 put options.
Mylan N.V. (NASDAQ:MYL) last posted its earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.18 by ($0.08). The business had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. Mylan N.V.’s revenue was up 15.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.16 earnings per share. Equities analysts predict that Mylan N.V. will post $4.57 EPS for the current fiscal year.
Several brokerages recently issued reports on MYL. Cowen and Company reissued a “hold” rating and set a $30.00 price objective (down previously from $43.00) on shares of Mylan N.V. in a research note on Wednesday, August 9th. Royal Bank Of Canada reissued a “sector perform” rating and set a $32.00 price objective (down previously from $33.00) on shares of Mylan N.V. in a research note on Thursday, August 10th. Citigroup Inc. raised shares of Mylan N.V. from a “neutral” rating to a “buy” rating and upped their price objective for the company from $36.00 to $42.00 in a research note on Wednesday, August 16th. Wells Fargo & Company set a $32.00 price objective on shares of Mylan N.V. and gave the company a “hold” rating in a research note on Wednesday. Finally, J P Morgan Chase & Co reissued an “overweight” rating and set a $48.00 price objective (up previously from $44.00) on shares of Mylan N.V. in a research note on Friday. One analyst has rated the stock with a sell rating, nine have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. Mylan N.V. has a consensus rating of “Buy” and a consensus price target of $41.99.
Mylan N.V. Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.